REGENXBIO Inc.

Rachunek Zysków i Strat





Przychody TTM (mln): 84
EBIT TTM (mln): -234
index 0 1 2 3 4 5 6 7 8 9 10 11
Rok finansowy 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 6 6 8 5 10 219 35 155 470 113 90 83
Przychód Δ r/r 0.0% 0.5% 24.0% -39.5% 126.5% 2002.4% -83.9% 338.7% 204.3% -76.0% -19.9% -7.7%
Marża brutto 94.7% 83.5% 80.2% 79.1% 83.6% 95.6% 76.6% 76.9% 89.0% 51.6% 39.6% 59.7%
EBIT (mln) -5 -4 -23 -65 -76 88 -149 -119 160 -263 -268 -233
EBIT Δ r/r 0.0% -22.9% 528.4% 182.4% 16.1% -216.1% -269.1% -20.0% -234.2% -264.3% 2.0% -13.0%
EBIT (%) -78.5% -60.2% -304.9% -1423.8% -730.2% 40.3% -422.9% -77.1% 34.0% -233.2% -297.1% -280.0%
Koszty finansowe (mln) 1 0 0 0 0 0 0 1 26 23 7 13
EBITDA (mln) -5 -4 -23 -65 -79 81 -198 -115 161 -263 -251 -198
EBITDA(%) -78.2% -59.7% -304.2% -1423.8% -756.3% 37.1% -560.7% -74.4% 34.2% -232.9% -277.9% -237.9%
Podatek (mln) 1 0 -0 -0 1 4 -3 5 13 -0 -0 0
Zysk Netto (mln) -5 -4 -23 -63 -73 100 -95 -111 128 -280 -263 -227
Zysk netto Δ r/r 0.0% -25.7% 469.8% 176.0% 16.2% -236.6% -194.8% 17.4% -214.9% -319.3% -6.0% -13.8%
Zysk netto (%) -88.5% -65.4% -300.6% -1372.1% -704.0% 45.7% -268.9% -72.0% 27.2% -248.7% -292.0% -272.5%
EPS -0.41 -0.3 -2.49 -2.38 -2.45 2.73 -2.58 -2.98 3.01 -6.5 -6.02 -4.59
EPS (rozwodnione) -0.41 -0.3 -2.49 -2.38 -2.45 2.73 -2.58 -2.98 2.91 -6.5 -6.02 -4.59
Ilośc akcji (mln) 13 13 9 26 30 37 37 37 42 43 44 50
Ważona ilośc akcji (mln) 13 13 9 26 30 37 37 37 44 43 44 50
Waluta USD USD USD USD USD USD USD USD USD USD USD USD